Pathfinder Cell Therapy, Inc. (PFND)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Dec 29, 2025
Pathfinder Cell Therapy Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
667.00
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | 54.00K | -60.00K | -52.63% |
| Dec 31, 2012 | 114.00K | 41.00K | 56.16% |
| Dec 31, 2011 | 73.00K | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| American Oriental Bioengineering | 121.58M |
| GlobeImmune | 6.21M |
| Alzex Neuropharma | 4.73M |
| Trevena | 546.00K |
| Proteonomix | 26.00K |